Optimist Retirement Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Sell
16,798
-2,181
-11% -$334K 1.13% 23
2025
Q4
$2.62M Sell
18,979
-340
-2% -$44.5K 1.2% 22
2025
Q3
$2.48M Buy
19,319
+47
+0.2% +$5.74K 1.12% 24
2025
Q2
$2.33M Buy
19,272
+69
+0.4% +$7.78K 1.12% 25
2025
Q1
$2.14M Buy
19,203
+137
+0.7% +$14.6K 1.07% 32
2024
Q4
$1.86M Sell
19,066
-247
-1% -$26.3K 0.88% 35
2024
Q3
$2.22M Buy
19,313
+166
+0.9% +$18.8K 1% 32
2024
Q2
$2.04M Buy
+19,147
New +$1.92M 1.07% 27

Other funds holding NVS

Optimist Retirement Group's NVS Position: Q1 2026 in Review

Optimist Retirement Group reduced its Novartis (NVS) stake by 11% in Q1 2026, selling an estimated $334K and leaving 16,798 shares worth $2.57M. The position accounts for 1.13% of the portfolio, ranked #23.

Optimist Retirement Group first reported a position in NVS in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.62M in Q4 2025. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Optimist Retirement Group held 16,798 shares of Novartis worth $2.57M as of Q1 2026.
  • Optimist Retirement Group sold 2,181 Novartis shares in Q1 2026, an estimated $334K.
  • Novartis made up 1.13% of Optimist Retirement Group's portfolio in Q1 2026, its #23 holding.
  • Optimist Retirement Group first reported a position in Novartis in Q2 2024 and has held it in 8 quarters since.
  • Optimist Retirement Group's Novartis position peaked at $2.62M in Q4 2025.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Optimist Retirement Group's 13F filing for Q1 2026, filed 11 May 2026.